MUNICH--(BUSINESS WIRE)--Daiichi Sankyo Europe, (hereafter, Daiichi Sankyo) today announced results from two prespecified analyses from the Phase 3 CLEAR (Cholesterol Lowering via Bempedoic Acid, an ...
This secondary data review template is an indicative template which can be customized based on the operational needs that are clarified in the assessment objectives and defined more clearly in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback